Production of OXA-48 carbapenemase acts as an independent risk factor for poor outcome in Klebsiella pneumoniae infection
出版年份 2023 全文链接
标题
Production of OXA-48 carbapenemase acts as an independent risk factor for poor outcome in Klebsiella pneumoniae infection
作者
关键词
-
出版物
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-27
DOI
10.1007/s10096-023-04675-w
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)
- (2022) Juan José Castón et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
- (2022) Christopher JL Murray et al. LANCET
- OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline
- (2022) Sara E. Boyd et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftazidime–avibactam treatment in bacteremia caused by OXA-48 carbapenemase-producing Klebsiella pneumoniae
- (2022) O. Lima et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- OXA-48 Carbapenemase-Producing Enterobacterales in Spanish Hospitals: An Updated Comprehensive Review on a Rising Antimicrobial Resistance
- (2021) Mario Rivera-Izquierdo et al. Antibiotics-Basel
- Increasing frequency of OXA-48-producing Enterobacterales worldwide and activity of ceftazidime/avibactam, meropenem/vaborbactam and comparators against these isolates
- (2021) Mariana Castanheira et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
- (2021) Mical Paul et al. CLINICAL MICROBIOLOGY AND INFECTION
- Risk factors for carbapenem-resistant Klebsiella pneumoniae infection relative to two types of control patients: a systematic review and meta-analysis
- (2020) Wei-min Zhu et al. Antimicrobial Resistance and Infection Control
- Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
- (2020) Matteo Bassetti et al. LANCET INFECTIOUS DISEASES
- A Cohort Study of the Impact of Carbapenem-Resistant Enterobacteriaceae Infections on Mortality of Patients Presenting with Sepsis
- (2019) Sabrina Sabino et al. mSphere
- Antimicrobial Resistance or Delayed Appropriate Therapy—Does One Influence Outcomes More Than the Other among Patients with Serious Infections due to Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacteriaceae?
- (2019) Thomas Lodise et al. Open Forum Infectious Diseases
- The effect of colistin resistance and other predictors on fatality among patients with bloodstream infections due to Klebsiella pneumoniae in an OXA-48 dominant region
- (2019) Şirin Menekşe et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Prognosis of urinary tract infection caused by KPC-producing Klebsiella pneumoniae: The impact of inappropriate empirical treatment
- (2019) Jorge Rodriguez-Gómez et al. JOURNAL OF INFECTION
- Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria
- (2019) Patrice Nordmann et al. CLINICAL INFECTIOUS DISEASES
- The Global Ascendency of OXA-48-Type Carbapenemases
- (2019) Johann D. D. Pitout et al. CLINICAL MICROBIOLOGY REVIEWS
- Assessment of Mortality Stratified by Meropenem MIC in Patients with Enterobacteriaceae Bacteremia: A Patient-level Analysis of Published Data
- (2019) J. Nicholas O'Donnell et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pathogenicity of Clinical OXA-48 Isolates and Impact of the OXA-48 IncL Plasmid on Virulence and Bacterial Fitness
- (2019) Axel Hamprecht et al. Frontiers in Microbiology
- Impact of the ST101 clone on fatality among patients with colistin-resistant Klebsiella pneumoniae infection
- (2018) Fusun Can et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- OUP accepted manuscript
- (2018) JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Whole genome sequencing, molecular typing and in vivo virulence of OXA-48-producing Escherichia coli isolates including ST131 H30-Rx, H22 and H41 subclones
- (2017) María de Toro et al. Scientific Reports
- Ceftazidime-avibactam as salvage therapy for infections caused by carbapenem-resistant organisms: a case series from the compassionate-use program
- (2016) Elizabeth Temkin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroSusceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014)
- (2016) Boudewijn L. M. de Jonge et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-ResistantEnterobacteriaceaeBacteremia
- (2016) Pranita D. Tamma et al. CLINICAL INFECTIOUS DISEASES
- Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain
- (2016) Zaira R. Palacios-Baena et al. JOURNAL OF INFECTION
- Prospective Multicenter Study of Carbapenemase-Producing Enterobacteriaceae from 83 Hospitals in Spain Reveals HighIn VitroSusceptibility to Colistin and Meropenem
- (2015) Jesús Oteo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial treatment and outcomes of critically ill patients with OXA-48like carbapenemase-producing Enterobacteriaceae infections
- (2015) Warren Lowman et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Mortality due toblaKPCKlebsiella pneumoniaebacteraemia
- (2015) Yedidah Fraenkel-Wandel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Characteristics, risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit
- (2015) Konstantinos Z. Vardakas et al. JOURNAL OF INFECTION
- Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival
- (2014) Ilker Inanç Balkan et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Clinical Outcomes of Enterobacteriaceae Infections Stratified by Carbapenem MICs
- (2014) Twisha S. Patel et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Chromosome-mediated OXA-48 carbapenemase in highly virulent Escherichia coli
- (2013) R. Beyrouthy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge
- (2012) C. Navarro-San Francisco et al. CLINICAL MICROBIOLOGY AND INFECTION
- Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis
- (2012) Wouter C. Rottier et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak
- (2012) J. R. Pano-Pardo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of OXA-48-producing Klebsiella pneumoniae and the novel carbapenemases OXA-244 and OXA-245 in Spain
- (2012) J. Oteo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: The study, the patient, the bug or the drug?
- (2012) Konstantinos Z. Vardakas et al. JOURNAL OF INFECTION
- Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections
- (2011) D. Ben-David et al. CLINICAL MICROBIOLOGY AND INFECTION
- Prospective Observational Study of the Impact of VIM-1 Metallo- -Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections
- (2009) G. L. Daikos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting
- (2008) Teresa C. Horan et al. AMERICAN JOURNAL OF INFECTION CONTROL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now